Cyclin B1 suppresses colorectal cancer invasion and metastasis by regulating E-cadherin

PLoS ONE

Volumn 10, Issue 5, 2015, Pages

  Fang, Yifeng ^a   Liang, Xiao ^a   Jiang, Wenbin ^a   Li, Jianbo ^a   Xu, Junfen ^b   Cai, Xiujun ^a  

^a ZHEJIANG UNIVERSITY   (China)

^b Womens Hospital   (China)

Author keywords

[No Author keywords available]

Indexed keywords

CYCLIN B1; UVOMORULIN; CADHERIN;

AGED; ARTICLE; CANCER INHIBITION; CANCER STAGING; CANCER SURVIVAL; CELL MIGRATION; COLORECTAL CANCER; COLORECTAL CANCER CELL LINE; CONTROLLED STUDY; DISTANT METASTASIS; DOWN REGULATION; FEMALE; GENE EXPRESSION REGULATION; GENE OVEREXPRESSION; HUMAN; HUMAN TISSUE; LYMPH NODE METASTASIS; MAJOR CLINICAL STUDY; MALE; OVERALL SURVIVAL; PROTEIN FUNCTION; PROTEIN PROCESSING; PROTEIN PROTEIN INTERACTION; SURVIVAL RATE; SURVIVAL TIME; TUMOR INVASION; UPREGULATION; CANCER GRADING; CELL MOTION; COLORECTAL TUMOR; GENE EXPRESSION; GENE SILENCING; GENETICS; METABOLISM; MIDDLE AGED; MORTALITY; PATHOLOGY; PROGNOSIS; TUMOR CELL LINE; TUMOR VOLUME; VERY ELDERLY;

AGED; AGED, 80 AND OVER; CADHERINS; CELL LINE, TUMOR; CELL MOVEMENT; COLORECTAL NEOPLASMS; CYCLIN B1; FEMALE; GENE EXPRESSION; GENE EXPRESSION REGULATION, NEOPLASTIC; GENE KNOCKDOWN TECHNIQUES; HUMANS; LYMPHATIC METASTASIS; MALE; MIDDLE AGED; NEOPLASM GRADING; NEOPLASM INVASIVENESS; NEOPLASM STAGING; PROGNOSIS; TUMOR BURDEN;

EID: 84930616965     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0126875     Document Type: Article

References (50)

1. Cunningham D, Atkin W, Lenz HJ, Lynch HT, Minsky B, Nordinger B, et al. (2010) Colorectal cancer. Lancet 375: 1030-1047. doi: 10.1016/S0140-6736(10)60353-4 PMID: 20304247
2. Kanthan R, Senger JL, Kanthan SC (2012) Molecular events in primary and metastatic colorectal carcinoma: a review. Pathology research international 2012: 597497. PMID: 22997602
3. Sengupta N, Gill KA, MacFie TS, Lai CS, Suraweera N, Mcdonald S, et al. (2008) Management of colorectal cancer: a role for genetics in prevention and treatment? Pathology, research and practice 204: 469-477. doi: 10.1016/j.prp.2008.03.003 PMID: 18534770
4. Siegel R, DeSantis C, Virgo K, Stein K, Mariotto A, Smith T, et al. (2012) Cancer treatment and survivorship statistics, 2012. CA Cancer J Clin 62: 220-241. doi: 10.3322/caac.21149 PMID: 22700443
5. Siegel R, Naishadham D, Jemal A (2012) Cancer statistics, 2012. CA Cancer J Clin 62: 10-29. doi: 10.3322/caac.20138 PMID: 22237781
6. Hanahan D, Weinberg RA (2011) Hallmarks of cancer: the next generation. Cell 144: 646-674. doi: 10.1016/j.cell.2011.02.013 PMID: 21376230
7. Pantel K, Brakenhoff RH (2004) Dissecting the metastatic cascade. Nature reviews Cancer 4: 448-456. PMID: 15170447
8. Valastyan S, Weinberg RA (2011) Tumor metastasis: molecular insights and evolving paradigms. Cell 147: 275-292. doi: 10.1016/j.cell.2011.09.024 PMID: 22000009
9. Lamouille S, Xu J, Derynck R (2014) Molecular mechanisms of epithelial-mesenchymal transition. Nature reviews Molecular cell biology 15: 178-196. doi: 10.1038/nrm3758 PMID: 24556840
10. Hur K, Toiyama Y, Takahashi M, Balaguer F, Nagasaka T, Koike J, et al. (2013) MicroRNA-200c modulates epithelial-to-mesenchymal transition (EMT) in human colorectal cancer metastasis. Gut 62: 1315-1326. doi: 10.1136/gutjnl-2011-301846 PMID: 22735571
11. Brabletz T, Hlubek F, Spaderna S, Schmalhofer O, Hiendlmeyer E, Jung A, et al. (2005) Invasion and metastasis in colorectal cancer: epithelial-mesenchymal transition, mesenchymal-epithelial transition, stem cells and beta-catenin. Cells, tissues, organs 179: 56-65. PMID: 15942193
12. Arias AM (2001) Epithelial mesenchymal interactions in cancer and development. Cell 105: 425-431. PMID: 11371340
13. Thiery JP, Acloque H, Huang RY, Nieto MA (2009) Epithelial-mesenchymal transitions in development and disease. Cell 139: 871-890. doi: 10.1016/j.cell.2009.11.007 PMID: 19945376
14. Onder TT, Gupta PB, Mani SA, Yang J, Lander ES, Weinberg RA (2008) Loss of E-cadherin promotes metastasis via multiple downstream transcriptional pathways. Cancer Res 68: 3645-3654. doi: 10.1158/0008-5472.CAN-07-2938 PMID: 18483246
15. Perl AK, Wilgenbus P, Dahl U, Semb H, Christofori G (1998) A causal role for E-cadherin in the transition from adenoma to carcinoma. Nature 392: 190-193. PMID: 9515965
16. Shiozaki H, Oka H, Inoue M, Tamura S, Monden M (1996) E-cadherin mediated adhesion system in cancer cells. Cancer 77: 1605-1613. PMID: 8608551
17. David JM, Rajasekaran AK (2012) Dishonorable discharge: the oncogenic roles of cleaved E-cadherin fragments. Cancer Res 72: 2917-2923. doi: 10.1158/0008-5472.CAN-11-3498 PMID: 22659456
18. Guaita S, Puig I, Franci C, Garrido M, Dominguez D, Batlle E, et al. (2002) Snail induction of epithelial to mesenchymal transition in tumor cells is accompanied by MUC1 repression and ZEB1 expression. The Journal of biological chemistry 277: 39209-39216. PMID: 12161443
19. Mani SA, Yang J, Brooks M, Schwaninger G, Zhou A, Miura N, et al. (2007) Mesenchyme Forkhead 1 (FOXC2) plays a key role in metastasis and is associated with aggressive basal-like breast cancers. Proc Natl Acad Sci U S A 104: 10069-10074. PMID: 17537911
20. Lin T, Ponn A, Hu X, Law BK, Lu J (2010) Requirement of the histone demethylase LSD1 in Snai1-mediated transcriptional repression during epithelial-mesenchymal transition. Oncogene 29: 4896-4904. doi: 10.1038/onc.2010.234 PMID: 20562920
21. Vesuna F, van Diest P, Chen JH, Raman V (2008) Twist is a transcriptional repressor of E-cadherin gene expression in breast cancer. Biochemical and biophysical research communications 367: 235-241. PMID: 18062917
22. Kwak JM, Min BW, Lee JH, Choi JS, Lee SI, Park SS, et al. (2007) The prognostic significance of E-cadherin and liver intestine-cadherin expression in colorectal cancer. Diseases of the colon and rectum 50: 1873-1880. PMID: 17828401
23. Hiscox S, Jiang WG (1997) Expression of E-cadherin, alpha, beta and gamma-catenin in human colorectal cancer. Anticancer Res 17: 1349-1354. PMID: 9137497
24. Rosivatz E, Becker I, Bamba M, Schott C, Diebold J, Mayr D, et al. (2004) Neoexpression of N-cadherin in E-cadherin positive colon cancers. Int J Cancer 111: 711-719. PMID: 15252840
25. Tsanou E, Peschos D, Batistatou A, Charalabopoulos A, Charalabopoulos K (2008) The E-cadherin adhesion molecule and colorectal cancer. A global literature approach. Anticancer Res 28: 3815-3826. PMID: 19189669
26. Matthess Y, Raab M, Sanhaji M, Lavrik IN, Strebhardt K (2010) Cdk1/cyclin B1 controls Fas-mediated apoptosis by regulating caspase-8 activity. Mol Cell Biol 30: 5726-5740. doi: 10.1128/MCB.00731-10 PMID: 20937773
27. Song Y, Zhao C, Dong L, Fu M, Xue L, Huang Z, et al. (2008) Overexpression of cyclin B1 in human esophageal squamous cell carcinoma cells induces tumor cell invasive growth and metastasis. Carcinogenesis 29: 307-315. PMID: 18048386
28. Kedinger V, Meulle A, Zounib O, Bonnet ME, Gossart JB, Benoit E, et al. (2013) Sticky siRNAs targeting survivin and cyclin B1 exert an antitumoral effect on melanoma subcutaneous xenografts and lung metastases. BMC Cancer 13: 338. doi: 10.1186/1471-2407-13-338 PMID: 23835136
29. Bonnet ME, Gossart JB, Benoit E, Messmer M, Zounib O, Moreau V, et al. (2013) Systemic delivery of sticky siRNAs targeting the cell cycle for lung tumor metastasis inhibition. Journal of controlled release: official journal of the Controlled Release Society 170: 183-190. doi: 10.1016/j.jconrel.2013.05.015 PMID: 23727288
30. Aaltonen K, Amini RM, Heikkila P, Aittomaki K, Tamminen A, Nevanlinna H, et al. (2009) High cyclin B1 expression is associated with poor survival in breast cancer. British journal of cancer 100: 1055-1060. doi: 10.1038/sj.bjc.6604874 PMID: 19293801
31. Begnami MD, Fregnani JH, Nonogaki S, Soares FA (2010) Evaluation of cell cycle protein expression in gastric cancer: cyclin B1 expression and its prognostic implication. Human pathology 41: 1120-1127. doi: 10.1016/j.humpath.2010.01.007 PMID: 20334896
32. Soria JC, Jang SJ, Khuri FR, Hassan K, Liu D, Hong WK, et al. (2000) Overexpression of cyclin B1 in early-stage non-small cell lung cancer and its clinical implication. Cancer Res 60: 4000-4004. PMID: 10945597
33. Arinaga M, Noguchi T, Takeno S, Chujo M, Miura T, Kimura Y, et al. (2003) Clinical implication of cyclin B1 in non-small cell lung cancer. Oncology reports 10: 1381-1386. PMID: 12883711
34. Nozoe T, Korenaga D, Kabashima A, Ohga T, Saeki H, Sugimachi K. (2002) Significance of cyclin B1 expression as an independent prognostic indicator of patients with squamous cell carcinoma of the esophagus. Clin Cancer Res 8: 817-822. PMID: 11895914
35. Grabsch H, Lickvers K, Hansen O, Takeno S, Willers R, Stock W, et al. (2004) Prognostic value of cyclin B1 protein expression in colorectal cancer. Am J Clin Pathol 122: 511-516. PMID: 15487447
36. Mashal RD, Lester S, Corless C, Richie JP, Chandra R, Propert KJ, et al. (1996) Expression of cell cycle-regulated proteins in prostate cancer. Cancer Res 56: 4159-4163. PMID: 8797586
37. Fang Y, Yu H, Liang X, Xu J, Cai X (2014) Chk1-induced CCNB1 overexpression promotes cell proliferation and tumor growth in human colorectal cancer. Cancer biology & therapy 15: 1268-1279.
38. Bjorck E, Ek S, Landgren O, Jerkeman M, Ehinger M, Björkholm M, et al. (2005) High expression of cyclin B1 predicts a favorable outcome in patients with follicular lymphoma. Blood 105: 2908-2915. PMID: 15576476
39. Shin JU, Lee CH, Lee KT, Lee JK, Lee KH, Kim KM, et al. (2012) Prognostic significance of ATM and cyclin B1 in pancreatic neuroendocrine tumor. Tumour biology: the journal of the International Society for Oncodevelopmental Biology and Medicine 33: 1645-1651. doi: 10.1007/s13277-012-0420-5 PMID: 22707287
40. Friedl P, Wolf K (2003) Tumour-cell invasion and migration: diversity and escape mechanisms. Nature reviews Cancer 3: 362-374. PMID: 12724734
41. Nimeus-Malmstrom E, Koliadi A, Ahlin C, Holmqvist M, Holmberg L, Amini RM, et al. (2010) Cyclin B1 is a prognostic proliferation marker with a high reproducibility in a population-based lymph node negative breast cancer cohort. Int J Cancer 127: 961-967. doi: 10.1002/ijc.25091 PMID: 19957331
42. Murakami H, Furihata M, Ohtsuki Y, Ogoshi S (1999) Determination of the prognostic significance of cyclin B1 overexpression in patients with esophageal squamous cell carcinoma. Virchows Archiv: an international journal of pathology 434: 153-158. PMID: 10071250
43. Weng L, Du J, Zhou Q, Cheng B, Li J, Zhang D, et al. (2012) Identification of cyclin B1 and Sec62 as biomarkers for recurrence in patients with HBV-related hepatocellular carcinoma after surgical resection. Mol Cancer 11: 39. doi: 10.1186/1476-4598-11-39 PMID: 22682366
44. Chae SW, Sohn JH, Kim DH, Choi YJ, Park YL, Kim K, et al. (2011) Overexpressions of Cyclin B1, cdc2, p16 and p53 in human breast cancer: the clinicopathologic correlations and prognostic implications. Yonsei medical journal 52: 445-453. doi: 10.3349/ymj.2011.52.3.445 PMID: 21488187
45. Li JQ, Kubo A, Wu F, Usuki H, Fujita J, Bandon S, et al. (2003) Cyclin B1, unlike cyclin G1, increases significantly during colorectal carcinogenesis and during later metastasis to lymph nodes. Int J Oncol 22: 1101-1110. PMID: 12684677
46. He X, Chen Z, Jia M, Zhao X (2013) Downregulated E-cadherin expression indicates worse prognosis in Asian patients with colorectal cancer: evidence from meta-analysis. PloS one 8: e70858. doi: 10.1371/journal.pone.0070858 PMID: 23923027
47. Bolos V, Peinado H, Perez-Moreno MA, Fraga MF, Esteller M, Cano A. (2003) The transcription factor Slug represses E-cadherin expression and induces epithelial to mesenchymal transitions: a comparison with Snail and E47 repressors. Journal of cell science 116: 499-511. PMID: 12508111
48. Wu WJ, Hirsch DS (2009) Mechanism of E-cadherin lysosomal degradation. Nature reviews Cancer 9: 143; author reply 143. doi: 10.1038/nrc2521-c1 PMID: 19148182
49. Nasulewicz A, Wietrzyk J, Wolf FI, Dzimira S, Madej J, Maier JA, et al. (2004) Magnesium deficiency inhibits primary tumor growth but favors metastasis in mice. Biochim Biophys Acta 1739: 26-32. PMID: 15607114
50. Murthy SR, Dupart E, Al-Sweel N, Chen A, Cawley NX, Loh YP. (2013) Carboxypeptidase E promotes cancer cell survival, but inhibits migration and invasion. Cancer letters 341: 204-213. doi: 10.1016/j.canlet.2013.08.011 PMID: 23941827